지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.2
- 수록면
- 33 - 39 (7page)
이용수
DBpia Top 0.5%동일한 주제분류 기준으로최근 2년간 이용수 순으로 정렬했을 때
해당 논문이 위치하는 상위 비율을 의미합니다.
초록· 키워드
오류제보하기
Objectives：To describe the differences in long-term outcomes in Alzheimer’s disease (AD) patients according to initial dementia severity.
Methods：A retrospective chart review of AD patients from a dementia clinic at the University Hospital in Korea was conducted from April 2010 to March 2017. There were 168 patients enrolled, who were divided into three groups based on initial Clinical Dementing Rating (CDR). There were 55 in the very mild group (CDR=0.5 ; mean age 80.64±6.57), 93 in the mild group (CDR=1 ; mean age 80.57±7.28) and 20 in the moderate group (CDR=2 ; mean age 83.00±9.07). Participants were treated with donepezil±memantine. The observation period was 2.44±0.50 years. Cognitive function and severity of dementia were initially assessed by the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-NP) and were annually assessed by Mini-Mental State Exam (MMSE), CDR and CDR-Sum of boxes (CDR-SB).
Results：The annual decline rate of MMSE score was -0.82 and those of very mild, mild, moderate groups were -0.63, -0.80, -1.96 respectively, while the annual change in CDR-SB score was 0.98, very mild group 0.86, mild group 1.03, moderate group 1.26. Education level, male, initial CDR were found to be significant potential factors in the annual change in MMSE, while initial CDR was a significant potential factor in the annual change in CDR-SB.
Conclusion：It is meaningful that we studied long-term outcomes of anti-dementia medications in real-world clinical setting. The higher the initial severity of AD, the higher the cognitive decline rate.
Methods：A retrospective chart review of AD patients from a dementia clinic at the University Hospital in Korea was conducted from April 2010 to March 2017. There were 168 patients enrolled, who were divided into three groups based on initial Clinical Dementing Rating (CDR). There were 55 in the very mild group (CDR=0.5 ; mean age 80.64±6.57), 93 in the mild group (CDR=1 ; mean age 80.57±7.28) and 20 in the moderate group (CDR=2 ; mean age 83.00±9.07). Participants were treated with donepezil±memantine. The observation period was 2.44±0.50 years. Cognitive function and severity of dementia were initially assessed by the Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery (CERAD-NP) and were annually assessed by Mini-Mental State Exam (MMSE), CDR and CDR-Sum of boxes (CDR-SB).
Results：The annual decline rate of MMSE score was -0.82 and those of very mild, mild, moderate groups were -0.63, -0.80, -1.96 respectively, while the annual change in CDR-SB score was 0.98, very mild group 0.86, mild group 1.03, moderate group 1.26. Education level, male, initial CDR were found to be significant potential factors in the annual change in MMSE, while initial CDR was a significant potential factor in the annual change in CDR-SB.
Conclusion：It is meaningful that we studied long-term outcomes of anti-dementia medications in real-world clinical setting. The higher the initial severity of AD, the higher the cognitive decline rate.
목차
서론
대상 및 방법
결과
고찰
참고문헌
참고문헌 (24)
참고문헌 신청
Youn JC / 2005 / Epidemiology of dementia / Psychiatry Investigation 2:8
Fratiglioni L / 2008 / Epidemiology of the dementia of old age / Oxford University press
Reisberg B / 2003 / Memantine in moderate-to-severe Alzheimer’s disease / New Engl J Med 348:1333~1341
Rolinski M / 2012 / Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease / Cochrane Database Syst Rev 2012:CD006504
Wang HF / 2015 / Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis / J Neurol Neurosurg Psychiatry 86:135~143
Fratiglioni L / 2008 / Epidemiology of the dementia of old age / Oxford University press
Reisberg B / 2003 / Memantine in moderate-to-severe Alzheimer’s disease / New Engl J Med 348:1333~1341
Rolinski M / 2012 / Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease / Cochrane Database Syst Rev 2012:CD006504
Wang HF / 2015 / Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis / J Neurol Neurosurg Psychiatry 86:135~143
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The Impact of the COVID-19 Pandemic and Social Distancing on Cognition of Alzheimer’s Disease Patients
PSYCHIATRY INVESTIGATION
2022 .11
-
Clinical Dementia Rating Orientation Score as an Excellent Predictor of the Progression to Alzheimer’s Disease in Mild Cognitive Impairment
PSYCHIATRY INVESTIGATION
2017 .07
-
초기 인지저하 단계에서 변화가 확인되는 신경심리영역
노인정신의학
2021 .10
-
뇌졸중 환자를 대상으로 한 인지선별검사(CIST), 한국판 간이정신상태검사 2판(K-MMSE~2) 및 임상치매척도(CDR)의 상관성
재활치료과학
2022 .05
-
Validity of the Tablet-Based Digital Cognitive Test (SCST) in Identifying Different Degrees of Cognitive Impairment
Journal of Korean Medical Science
2024 .09
-
Cervical Disc Replacement: Trends, Costs, and Complications
Asian Spine Journal
2020 .01
-
Effect of Dietary Habits on Alzheimer’s Disease Progression
Yonsei Medical Journal
2024 .04
-
The Effect of Cognitive Training in a Day Care Center in Patients with Early Alzheimer’s Disease Dementia: A Retrospective Study
PSYCHIATRY INVESTIGATION
2020 .01
-
Associations between Optic Cup-to-disc Ratio and Systemic Factors in the Healthy Korean Population
Korean Journal of Ophthalmology
2015 .01
-
The Clinical Characteristics according to the Educational Level in the Elderly Patients with Mild Alzheimer’s Disease Dementia
Dementia and Neurocognitive Disorders(대한치매학회지)
2015 .01
-
Characteristics of Cognitive Function Changes and Related Factors in Individuals With Cognitive Impairment During the Pandemic of COVID-19: A Retrospective Chart Review Study
PSYCHIATRY INVESTIGATION
2023 .02
-
알츠하이머병과 경도인지장애에서 체질량지수와 인지기능과의 연관성
정신신체의학
2016 .01
-
Real-world Evaluation of Tolerability, Safety and Efficacy of Rivastigmine Oral Solution in Patients with Mild to Moderate Alzheimer’s Disease Dementia
Clinical Psychopharmacology and Neuroscience
2021 .08
-
알츠하이머병과 경도인지장애에서 헤모글로빈 농도와 인지기능과의 연관성
정신신체의학
2016 .01
-
귀비탕 가미방을 포함한 한방치료로 호전된 알코올성 치매 환자 1례
대한한방내과학회지
2016 .01
-
Modified Criteria for Diagnosing “Cognitive Frailty”
PSYCHIATRY INVESTIGATION
2018 .01
-
알츠하이머형 치매 및 경도인지장애 환자에서 인지기능 및 행동심리증상과 내측두엽 위축의 연관성
정신신체의학
2019 .01
-
History of Alzheimer’s Disease
Dementia and Neurocognitive Disorders(대한치매학회지)
2016 .12
-
경증치매 환자에게 적용한 작업치료 중심의 인지재활이 미치는 효과
고령자･치매작업치료학회지
2015 .01
-
Subjective Cognitive Decline in Community-Dwelling Older Adults With Objectively Normal Cognition: Mediation by Depression and Instrumental Activities of Daily Living
PSYCHIATRY INVESTIGATION
2024 .06
이 논문의 저자 정보
이 논문과 함께 이용한 논문
알츠하이머 치매에 대한 뇌자극 치료
김해유
,
박진세
,
이해구
대한인간공학회 학술대회논문집
2018
.11
알츠하이머 치매 진단에 영향을 미치는 검사도구 분석
박이랑
,
강광순
한국엔터테인먼트산업학회논문지
2021
.01
알츠하이머병에서 아세틸콜린에스테라제 억제제에 대한 치료 반응과 관련된 요인
한송이
,
이미지
,
김정란
생물치료정신의학
2015
.06
치매환자 100만 명 시대, 치료제 개발 어디까지? : 흔들리는 아밀로이드 베타 가설, 국내 연구진 치매의 새로운 원인 제시
장래혁
브레인
2020
.12
암 치료를 위한 항체치료제에 대한 고찰: 면역항암제
유한진
,
홍세영
,
권미지
외 3명
KSBB Journal
2020
.06
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-512-001586217